Supplemental material
Modern Rheumatology
Volume 27, 2017 - Issue 2
Open access
3,608
Views
26
CrossRef citations to date
0
Altmetric
Original Article
Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study
Naoki IshiguroDepartment of Orthopedic Surgery, Nagoya University Graduate School & Faculty of Medicine, Nagoya, Japan, Correspondence[email protected]
, Tatsuya AtsumiHokkaido University Graduate School of Medicine, Sapporo, Japan,
, Masayoshi HarigaiDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan,
, Tsuneyo MimoriDepartment of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan,
, Norihiro NishimotoOsaka Rheumatology Clinic, Tokyo Medical University, Osaka, Japan,
, Takayuki SumidaDivision of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan,
, Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University, Minato, Japan,
, Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan,
, Ayako NakasonePharmacovigilance Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan,
, Nobuhiro TakagiMedical Science Department, Chugai Pharmaceutical Co. Ltd., Tokyo, Japan, and
& Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
show all
Pages 217-226
|
Received 10 Mar 2016, Accepted 14 Jun 2016, Published online: 14 Jul 2016
Related Research Data
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry.
Source:
Springer Science and Business Media LLC
Targeting primary Sjögren’s syndrome
Source:
Informa UK Limited
Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: Continued observations
Source:
Wiley
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
Source:
The Journal of Rheumatology
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab
Source:
HAL CCSD
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
Source:
Oxford University Press (OUP)
Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan.
Source:
Oxford University Press (OUP)
Postmarketing surveillance of the safety and effectiveness of etanercept in Japan
Source:
The Journal of Rheumatology
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs
Source:
Elsevier BV
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.
Source:
Academy of Managed Care Pharmacy
MODIFIED DISEASE ACTIVITY SCORE
Source:
Wiley
Low Dose Long-Term Corticosteroid Therapy in Rheumatoid Arthritis: An Analysis of Serious Adverse Events
Source:
Elsevier BV
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
Source:
Oxford University Press (OUP)
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice.
Source:
Springer Science and Business Media LLC
Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
Source:
Informa Healthcare
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
Source:
Informa UK Limited
Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
Source:
Informa UK Limited
Longterm Safety of Tocilizumab: Results from 3 Years of Followup Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan
Source:
The Journal of Rheumatology
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Source:
Oxford University Press (OUP)
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
Source:
Oxford University Press (OUP)
Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies
Source:
Springer Science and Business Media LLC
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
Source:
Springer Nature
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.